                         SEQUENCE LISTING

<110>  Ionis Pharmaceuticals, Inc.
 
<120>  GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS

<130>  BIOL0311WO

<150>  62/399,233
<151>  2016-09-23

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
gccaggctgg ttatgactca                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
ctcacttttc gaggttccta                                                   20


